Swedish Orphan Biovitrum AB (publ) (B6E.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 11:45AM CEST
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 8.27B |
| Enterprise Value | 9.87B |
| Trailing P/E | 45.12 |
| Forward P/E | 28.17 |
| PEG Ratio (5 yr expected) | 1.39 |
| Price/Sales (ttm) | 4.11 |
| Price/Book (mrq) | 2.70 |
| Enterprise Value/Revenue | 0.43 |
| Enterprise Value/EBITDA | 1.35 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.26 |
| 52-Week Change 3 | 15.48% |
| S&P500 52-Week Change 3 | 23.10% |
| 52 Week High 3 | 26.46 |
| 52 Week Low 3 | 16.13 |
| 50-Day Moving Average 3 | 23.23 |
| 200-Day Moving Average 3 | 21.28 |
Share Statistics
| Avg Vol (3 month) 3 | 8 |
| Avg Vol (10 day) 3 | 35 |
| Shares Outstanding 5 | 339.87M |
| Implied Shares Outstanding 6 | 340.17M |
| Float 8 | 198.7M |
| % Held by Insiders 1 | 10.08% |
| % Held by Institutions 1 | 73.89% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in SEK.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 9.26% |
| Operating Margin (ttm) | 23.47% |
Management Effectiveness
| Return on Assets (ttm) | 4.51% |
| Return on Equity (ttm) | 6.72% |
Income Statement
| Revenue (ttm) | 23.14B |
| Revenue Per Share (ttm) | 69.38 |
| Quarterly Revenue Growth (yoy) | 19.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | 7.77B |
| Net Income Avi to Common (ttm) | 2.14B |
| Diluted EPS (ttm) | 0.54 |
| Quarterly Earnings Growth (yoy) | -25.00% |
Balance Sheet
| Total Cash (mrq) | 527M |
| Total Cash Per Share (mrq) | 1.55 |
| Total Debt (mrq) | 19.22B |
| Total Debt/Equity (mrq) | 53.54% |
| Current Ratio (mrq) | 0.71 |
| Book Value Per Share (mrq) | 3.55 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.74B |
| Levered Free Cash Flow (ttm) | 2.69B |
© 2024 Yahoo. All rights reserved.